Evaluation of X-ray tomography contrast agents: A review of production, protocols, and biological applications.
Clicks: 190
ID: 93450
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.7
/100
9 views
9 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
X-ray computed tomography is a strong tool that finds many applications both in medical applications and in the investigation of biological and nonbiological samples. In the clinics, X-ray tomography is widely used for diagnostic purposes whose three-dimensional imaging in high resolution helps physicians to obtain detailed image of investigated regions. Researchers in biological sciences and engineering use X-ray tomography because it is a nondestructive method to assess the structure of their samples. In both medical and biological applications, visualization of soft tissues and structures requires special treatment, in which special contrast agents are used. In this detailed report, molecule-based and nanoparticle-based contrast agents used in biological applications to enhance the image quality were compiled and reported. Special contrast agent applications and protocols to enhance the contrast for the biological applications and works to develop nanoparticle contrast agents to enhance the contrast for targeted drug delivery and general imaging applications were also assessed and listed.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (154 words).
Try re-searching for a better abstract.
| Reference Key |
koc2019evaluationmicroscopy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Koç, Mümin Mehmet;Aslan, Naim;Kao, Alexander P;Barber, Asa H; |
| Journal | Microscopy research and technique |
| Year | 2019 |
| DOI |
10.1002/jemt.23225
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.